Scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, have published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

POPULIST POLITICS

INCREASINGLY, the country is being drawn into very dangerous populist politics that are high in emotion but very low in substance. Very high in simplistic solution but very low in practical, cogent and logical argumentation towards improving living condition for the ordinary Zambian.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.